ANI Pharmaceuticals
ANIP
#4828
Rank
โ‚น166.21 B
Marketcap
โ‚น7,401
Share price
0.12%
Change (1 day)
47.40%
Change (1 year)

ANI Pharmaceuticals (ANIP) - P/B ratio

P/B ratio as of December 2025 : 3.65

According to ANI Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 2.23311.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

ANI Pharmaceuticals - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-312.678.42%
2023-12-312.4618.67%
2022-12-312.07-3.13%
2021-12-312.1416.7%
2020-12-311.83-47.68%
2019-12-313.5129.54%
2018-12-312.71-37.01%
2017-12-314.303.77%
2016-12-314.1427.67%
2015-12-313.24-29.45%
2014-12-314.60-2.6%
2013-12-314.72341.64%
2012-12-311.07-26.81%
2011-12-311.46-79.15%
2010-12-317.0042.54%
2009-12-314.91147.68%
2008-12-311.98-42.61%
2007-12-313.46-3.48%
2006-12-313.58-65.51%
2005-12-3110.455.93%
2004-12-316.660.11%
2003-12-316.657.11%
2002-12-316.21

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Jazz Pharmaceuticals
JAZZ
2.55-30.22%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
4.31 18.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
4.73 29.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
1.57-57.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
-0.0179-100.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
3.17-13.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
-17.3-573.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.69 55.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
2.32-36.52%๐Ÿ‡ฌ๐Ÿ‡ง UK